These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2259550)

  • 1. Diagnosis and management of familial dyslipoproteinemia in children and adolescents.
    Kwiterovich PO
    Pediatr Clin North Am; 1990 Dec; 37(6):1489-523. PubMed ID: 2259550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial lipoprotein disorders in patients with premature coronary artery disease.
    Genest JJ; Martin-Munley SS; McNamara JR; Ordovas JM; Jenner J; Myers RH; Silberman SR; Wilson PW; Salem DN; Schaefer EJ
    Circulation; 1992 Jun; 85(6):2025-33. PubMed ID: 1534286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Atherosclerosis and juvenile dyslipidemias].
    Calvani M
    Recenti Prog Med; 1994 Mar; 85(3):204-11. PubMed ID: 8184205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of dyslipoproteinemia with the use of plasma total cholesterol and triglyceride as screening tests. The Lipid Research Clinics Program Prevalence Study.
    Kwiterovich PO; Stewart P; Probstfield JL; Stinnett S; Chambless LE; Chase GA; Jacobs DR; Morrison JA
    Circulation; 1986 Jan; 73(1 Pt 2):I30-9. PubMed ID: 3940681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary and familial hypoalphalipoproteinemia.
    Third JL; Montag J; Flynn M; Freidel J; Laskarzewski P; Glueck CJ
    Metabolism; 1984 Feb; 33(2):136-46. PubMed ID: 6694557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic aspects of primary atherogenic dyslipoproteinemia].
    Turpin G; Bruckert E
    C R Seances Soc Biol Fil; 1995; 189(5):905-17. PubMed ID: 8673636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity.
    Kwiterovich PO
    Am J Cardiol; 2002 Oct; 90(8A):30i-47i. PubMed ID: 12419479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein B as a marker of familial hyperlipoproteinemia.
    Sveger T; Nordborg K
    J Atheroscler Thromb; 2004; 11(5):286-92. PubMed ID: 15557711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyslipoproteinemia and other risk factors for atherosclerosis in children and adolescents.
    Kwiterovich PO
    Atherosclerosis; 1994 Aug; 108 Suppl():S55-71. PubMed ID: 7802729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks.
    Otto C; Ritter MM; Richter WO; Minkenberg R; Schwandt P
    Metabolism; 2001 Feb; 50(2):166-70. PubMed ID: 11229424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening, diagnosis, and management of dyslipoproteinemia in children.
    Franklin FA; Brown RF; Franklin CC
    Endocrinol Metab Clin North Am; 1990 Jun; 19(2):399-449. PubMed ID: 2192880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial aggregation of lipids and lipoproteins and early identification of dyslipoproteinemia. The Collaborative Lipid Research Clinics Family Study.
    Morrison JA; Namboodiri K; Green P; Martin J; Glueck CJ
    JAMA; 1983 Oct; 250(14):1860-8. PubMed ID: 6620483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial lipoprotein lipase and apolipoprotein C-II deficiency. Lipoprotein and apoprotein analysis, adipose tissue and hepatic lipoprotein lipase levels in seven patients and their first degree relatives.
    Fellin R; Baggio G; Poli A; Augustin J; Baiocchi MR; Baldo G; Sinigaglia M; Greten H; Crepaldi G
    Atherosclerosis; 1983 Oct; 49(1):55-68. PubMed ID: 6651913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterozygous familial hypercholesterolemia in children: low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations.
    Torres AL; Moorjani S; Vohl MC; Gagné C; Lamarche B; Brun LD; Lupien PJ; Després JP
    Atherosclerosis; 1996 Sep; 126(1):163-71. PubMed ID: 8879444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Physiology and pathophysiology of the metabolism of lipoproteins].
    Sandhofer F
    Wien Med Wochenschr; 1994; 144(12-13):286-90. PubMed ID: 8650930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperapo-beta-emia in children. Study of 17 families].
    Sarriá Chueca A; Moreno Aznar L; Mur Llorente M; Lázaro Almarza A; Roda Altes L; Giner Soria A; Bueno Sánchez M
    An Esp Pediatr; 1992 Jul; 37(1):52-6. PubMed ID: 1416524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dyslipoproteinemias after heart and heart-lung transplantation: potential relation to accelerated graft arteriosclerosis.
    Bilodeau M; Fitchett DH; Guerraty A; Sniderman AD
    J Heart Transplant; 1989; 8(6):454-9. PubMed ID: 2614546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease].
    Breier C
    Wien Klin Wochenschr Suppl; 1986; 167():1-16. PubMed ID: 3458343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.